Early in the COVID-19 pandemic, it was established that a raised CRP, which is widely used as a biomarker of bacterial infection in the UK, reflected severity of illness rather than bacterial superinfection in COVID-19 patients [17]. This evidence concerns the gene CRP and COVID-19.